buyers have dis-appeared... no support... 1.4c, looks cheap to get into..this will pay back in the long run..
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025